Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence

scientific article published on 4 June 2013

Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00330-013-2901-3
P698PubMed publication ID23732687

P50authorLars A. AkslenQ11983239
Helga SalvesenQ27506003
Ingfrid S HaldorsenQ30512739
Jone TrovikQ42385777
Line BjørgeQ88738335
Henrica M J WernerQ114341798
P2093author name stringInger J Magnussen
Jenny A Husby
Renate Grüner
Ingunn Stefansson
Torfinn Taxt
Oyvind O Salvesen
P2860cites workHallmarks of Cancer: The Next GenerationQ22252312
Molecular mechanisms and clinical applications of angiogenesisQ29547314
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.Q33744660
A phase 3 trial of bevacizumab in ovarian cancerQ34030022
Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.Q37385863
Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.Q37401547
Novel imaging techniques as response biomarkers in cervical cancerQ37683110
Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.Q37960457
Staging of endometrial carcinomas with MRI using traditional and novel MRI techniquesQ37961360
Markers for individualised therapy in endometrial carcinomaQ38030768
Radiologic staging in patients with endometrial cancer: a meta-analysisQ41689161
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistanceQ44075517
Single-channel blind estimation of arterial input function and tissue impulse response in DCE-MRI.Q44358859
Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.Q45908100
An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivationQ48331032
Iterative blind deconvolution in magnetic resonance brain perfusion imagingQ48623670
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.Q51554708
Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.Q53385495
Revised FIGO staging for carcinoma of the vulva, cervix, and endometriumQ63199181
Endometrial cancerQ63199203
Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancerQ80531685
Diffusion-weighted MR imaging of uterine endometrial cancerQ80868097
Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysisQ84926285
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectendometrial carcinomaQ18555222
P304page(s)2916-2925
P577publication date2013-06-04
P1433published inEuropean RadiologyQ5413071
P1476titleDynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence
P478volume23

Reverse relations

cites work (P2860)
Q58283711Endometrial Cancer
Q51102192Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imaging.
Q37459631Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
Q47879262In vivo MR spectroscopy predicts high tumor grade in endometrial cancer
Q61817355Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer
Q41878396Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers
Q48305261Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer
Q35121869Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas
Q38436640Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer
Q42317488Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
Q49772175Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
Q28077761What Is the Best Preoperative Imaging for Endometrial Cancer?
Q50145613What's New in Imaging for Gynecologic Cancer?

Search more.